FDA Considers Making Narcan Opioid Overdose Antidote Available Without Prescription

Two hands cradling a nasal spray dispenser for naloxone.
February 15, 2023
Clinical Associate Professor in the Division of Pharmacotherapy Dr. Kirk Evoy spoke to CNN about the possibilities of making naloxone, a medication used to reverse or reduce the effects of opioids, available over-the-counter.

Reveles and Evoy Earn Promotions

A woman and a man smiling.
February 25, 2022
Two of the college's distinguished faculty in the Division of Pharmacotherapy were recommended for promotion by President Hartzell. Dr. Kelly R. Reveles will assume the rank of associate professor and Dr. Kirk Evoy will become a clinical associate professor. Both promotions go into effect September 1, 2022.

TxCORE Research Wins PhRMA Foundation Award

Three people smiling.
April 1, 2021
Three researchers from the College of Pharmacy won an award from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation. Leticia R. Moczygemba, Pharm.D., Ph.D., Carolyn M. Brown, Ph.D. and Michael Johnsrud, Ph.D., R.Ph. were awarded $5,000 from the PhRMA Foundation for their proposal to advance racial and ethnic representation in value assessments.

Nixon and Hill Earn Faculty Promotions

A woman smiling and a man wearing glasses.
March 24, 2021
Two of the College of Pharmacy’s distinguished faculty were recently promoted due to their outstanding accomplishments in research, outreach and education. Dr. Kimberly Nixon of the Division of Pharmacology and Toxicology will assume the rank of professor and Dr. Lucas G. Hill of the Division of Pharmacy Practice will become a clinical associate professor.

Peppas to Receive Prestigious Oesper Award in Honor of Contributions to Chemistry

A smiling man standing in front of a bookshelf.
November 4, 2020
Nicholas A. Peppas, Sc.D. has been honored with the 2020 Oesper Award from the University of Cincinnati’s Chemistry Department and the Cincinnati Section of the American Chemical Society for his outstanding accomplishments in and contributions to science. The award recognizes his work in biomaterials, drug delivery, bionanotechnology, and nanomaterials.

Inhaled Niclosamide a Potential Effective Antiviral to Treat COVID-19

An infrared image of nasal spray being administered.
September 29, 2020
Researchers in the lab of Dr. Hugh D.C. Smyth have released promising results of a new method to treat SARS-CoV-2, the coronavirus that causes COVID-19. The antiviral niclosamide, when incorporated with human lysozyme as a carrier molecule, shows potential as an effective COVID-19 treatment when delivered directly to the airways.

Brown inducted into Provost’s Distinguished Service Academy

Brown Headshot
February 4, 2020
Health Outcomes Professor Carolyn Brown, Ph.D. was one of five accomplished faculty members at The University of Texas at Austin to be inducted into the first cohort of the Provost’s Distinguished Service Academy (DSA).